NCT01969214View on ClinicalTrials.gov

Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Diarrhoea
Interventions
DEVICE

IQP-MM-101

"Dissolve the effervescent tablets in half a glass of water, to be taken orally~1 tablet, 3 times a day"

Trial Locations (1)

10369

analyze & realize GmbH, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY

NCT01969214 - Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea | Biotech Hunter | Biotech Hunter